pasireotide and Paraneoplastic-Syndromes

pasireotide has been researched along with Paraneoplastic-Syndromes* in 1 studies

Other Studies

1 other study(ies) available for pasireotide and Paraneoplastic-Syndromes

ArticleYear
Positive somatostatin receptor imaging does not predict somatostatin analogue efficacy in tumor-induced osteomalacia.
    Polish archives of internal medicine, 2018, 09-28, Volume: 128, Issue:9

    Topics: Adult; Antineoplastic Agents, Hormonal; Humans; Male; Mesenchymoma; Neoplasms, Connective Tissue; Octreotide; Osteomalacia; Paraneoplastic Syndromes; Receptors, Somatostatin; Somatostatin; Treatment Outcome

2018